Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


Patient Advocates for Advanced Cancer Treatments


Address

PO Box 141695
Grand Rapids, MI 49514 USA

Phone

6164531477

Fax

6164531846

Email Address

paact@paactusa.org

Description

The Patient Advocates for Advanced Cancer Treatments (PAACT) is a non-profit advocacy organization dedicated to finding answers for individuals with prostate cancer. Prostate cancer is a prevalent form of cancer affecting the prostate gland in males. PAACT is a place where affected individuals can obtain information. The PAACT organization is comprised of lay people and physicians who have in common a sincere desire to help affected individuals become aware of the present understanding of prostate cancer; to allow an affected individual to participate in his own healing; and finally, to direct an affected individual to the appropriate physicians, and medical centers to achieve these goals. Established in 1983, PAACT maintains constant research of medical documents, and clinical studies on the most advanced methods of detection, diagnostic procedures, evaluation, and treatments for prostate cancer. Is also committed to furnishing affected individuals, physicians, and advocates with the results of these studies. Consisting of 37,000 members and 150 chapters, the organization produces educational materials including the "PAACT Patient Information Package," and a quarterly newsletter entitled "Prostate Cancer Communication."

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.